Studies have demonstrated that silencing GLUT1 expression effectively reduces glioma stem cell (GSC) tumor sphere formation, decreases self-renewal and proliferation in vitro, indicating its potential as a therapeutic target in GBM (46). This evidence concerns the gene SLC2A1 and neoplasm.